E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 12/5/2016 in the Prospect News High Yield Daily and Prospect News Liability Management Daily.

AmSurg calls remaining $12.33 million of 5 5/8% notes due 2020

New York, Dec. 5 – AmSurg Corp. will redeem its remaining $12,329,000 of 5 5/8% notes due 2020 on Jan. 3.

The issuer will pay 103.813% of par plus accrued interest, according to an announcement.

The company is currently conducting a tender offer for the notes.

As of the early deadline, 5 p.m. ET on Nov. 28, holders of 95.07% of the outstanding notes had tendered and also delivered consents to planned amendments to the notes.

The price on offer for those who tendered by the early deadline was $1,031.88 per $1,000 principal amount, a sum that includes a consent payment of $30.00 per $1,000 principal amount only payable to those who tendered by the early deadline.

The tender offer is scheduled to expire at midnight ET on Dec. 12.

Before the offer began, the company had $250 million of the notes outstanding.

The tender offer and consent solicitation are conditioned on the company completing its previously announced acquisition by Envision Healthcare Holdings, Inc. and one or more debt financing transactions. The company announced on Dec. 1 that it completed the merger.

AmSurg is a Nashville operator of ambulatory surgery centers.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.